Anastrozole Tablet, Film Coated
Product Images NDC 42291-085

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Anastrozole (NDC 42291-085). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

1mg (085 30 1mg)

1mg (085 30 1mg)
FDA Label Image

085 90 1mg

085 90 1mg
FDA Label Image

Anastrozole Structural Formula (Anastrozole Tablets Usp A078058 1)

Anastrozole Structural Formula (Anastrozole Tablets Usp A078058 1)
FDA Label Image

Fig1 (Anastrozole Tablets Usp A078058 2)

Fig1 (Anastrozole Tablets Usp A078058 2)
FDA Label Image

Figure 2 — (Anastrozole Tablets Usp A078058 3)

Figure 2 — (Anastrozole Tablets Usp A078058 3)
FDA Label Image

Figure 3 (- Anastrozole Tablets Usp A078058 4)

Figure 3 (- Anastrozole Tablets Usp A078058 4)
FDA Label Image

Figure 4 (- Anastrozole Tablets Usp A078058 5)

Figure 4 (- Anastrozole Tablets Usp A078058 5)
FDA Label Image

Figure 5 (Kaplan-Meier Probability of Time to Disease Progression for All Randomized Patients (Intent-to-Treat) in Trial 0030)

Figure 5 (Kaplan-Meier Probability of Time to Disease Progression for All Randomized Patients (Intent-to-Treat) in Trial 0030)
FDA Label Image

Figure 6 (Kaplan-Meier Probability of Time to Progression for All Randomized Patients (Intent-to-Treat) in Trial 0027)

Figure 6 (Kaplan-Meier Probability of Time to Progression for All Randomized Patients (Intent-to-Treat) in Trial 0027)